Who Can Take Wegovy 7.2 mg, and Am I Eligible?

Wegovy, a weight-management treatment containing semaglutide, has become widely used in the UK for people living with obesity or overweight who struggle with traditional weight-loss methods. The standard maintenance dose is 2.4 mg once weekly, but clinical trials have introduced a higher 7.2 mg strength. So, who is this new dose for, and how do you know if you might be eligible?

What is Wegovy 7.2 mg?

The 7.2 mg injection is a higher-strength version of semaglutide. It is not intended for beginners, but rather for people who have already gone through the full titration schedule (0.25 mg up to 2.4 mg) and are tolerating treatment well. The new dose is being studied as an option for those who may need additional support if results plateau on 2.4 mg.

Who Can Take Wegovy 7.2 mg?

Based on clinical trial data and current usage guidelines for lower doses, candidates for Wegovy 7.2 mg are typically:

• Adults with obesity (BMI ≥30)
• Adults who are overweight (BMI ≥27) with a weight-related condition, such as high blood pressure, type 2 diabetes, or sleep apnoea
• People who have already completed the standard dose-escalation schedule and still require greater weight-loss support
• Patients who are tolerating Wegovy 2.4 mg without serious side effects

It is important to note that 7.2 mg is not yet approved in the UK and is still under review by the European Medicines Agency, and eligibility will depend on regulatory decisions, as well as individual assessments by healthcare professionals.

Who Should Not Take Wegovy 7.2 mg?

As with all semaglutide treatments, it may not be suitable for everyone. Wegovy 7.2 mg is generally not recommended for:

• People with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 syndrome.
• Anyone with a history of severe allergic reaction to semaglutide or other ingredients in Wegovy.
• Patients with certain gastrointestinal conditions or a history of severe pancreatitis.
• Those who cannot tolerate lower doses of Wegovy or have not been through the dosing sequence in order.

Am I Eligible?

If you are already using Wegovy and feel you have reached a point in your current weight loss treatment on the 2.4mg where your weight is plateauing, your prescriber may consider a higher dose once it becomes available. Eligibility will be determined on an individual basis, taking into account your medical history, progress, and ability to tolerate the medicine.

Key Takeaway

Wegovy 7.2 mg is designed for people who have already tried and tolerated lower doses but need further support in their weight-loss journey. Until it is officially approved in the UK, eligibility remains dependent on ongoing clinical trials and regulatory review. Once this strength is released in the market, you will be able to buy Wegovy 7.2mg online in the UK from Pharmacy Planet, the UK’s trusted online weight loss clinic.